Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes

Yvonne Fierz, Ruslan Novosyadlyy, Archana Vijayakumar, Shoshana Yakar, Derek LeRoith

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences